However, there is potential for more serious adverse effects, such as: 1 Vision problems Swelling in the extremities Dizziness or fainting Reduced urination Rash Rapid heart rate Swelling of the throat, tongue, mouth, face, or eyes Problems swallowing or breathing Fever Yellow eyes or skin Chronic upper stomach pain Wegovy, another brand name for semaglutide, may also cause damage to the retina, suicidal ideation, gallstones, pancreatitis, and acute kidney damage
Transforming growth factor-beta (TGF-beta). The international journal of biochemistry & cell biology vol
Key Trial Results CagriSema delivered solid weight loss, but not enough to meet the primary endpoint of non-inferiority versus tirzepatide
The medication has shown promising results for weight loss in people without diabetes, as well
Individuals with type 2 diabetes receiving GLP-1RA may discontinue treatment because of gastrointestinal side effects that can be associated with these drugs, a lack of efficacy, patient expectations or other reasons [8]